Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Novartis Pharmaceuticals Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified healthcare advice, calls or treatment using a genuine physician. We are not mDs. Always confer with your dr. on Novartis Pharmaceuticals clinical studies. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Novartis Pharmaceuticals Clinical research trials and Novartis Pharmaceuticals health trials take place in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations like Novartis Pharmaceuticals to discover treatments for all forms of conditions. Novartis Pharmaceuticals Clinical Trials and other clinical trials allow volunteers to undergo medical treatment alternatives before they are available to the masses. Most times the test subjects undergo professional assistance for free, and every now and again they are paid for their time. Sometimes there is a cost for a Novartis Pharmaceuticals clinical trial. Subjects typically get the best healthcare possible for their condition. Risks are a reality, nonetheless, and may include additional or frequent physician trips, medical hazards (perhaps life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with rigorous guidelines to protect clinical trials subjects.

Home > "N" Clinical Trials Sponsors > Novartis Pharmaceuticals Clinical Trials

Novartis Pharmaceuticals Clinical Trials



A 12-week, multicenter, safety and dose-ranging study of 3 oral doses of TCH346 in patients with Amyotrophic Lateral Sclerosis
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

An open-label, phase II trial of PKC412 monotherapy in patients with acute myeloid leukemia and patients with myelodysplastic syndrome
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Bisphosphonate Treatment of Osteogenesis Imperfecta
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

EPO906 in Carcinoid and other Neuroendocrine Tumors
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

EPO906 Therapy in Patients with Advanced Breast Cancer
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

EPO906 Therapy in Patients with Advanced Colorectal Cancer
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

EPO906 Therapy in Patients with Advanced Kidney Cancer
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

EPO906 Therapy in Patients with Advanced Melanoma
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

EPO906 Therapy in Patients with Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

EPO906 Therapy in Patients with Prostate Cancer
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

First-line treatment of metastatic colorectal cancer with oxaliplatin/5-FU/leucovorin plus PTK787/ZK 222584 or placebo
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

HORIZON-PFT: Pivotal Fracture Trial
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Investigation into Delay to Diagnosis of Alzheimer's Disease with Exelon (InDDEx)
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

New bisphosphonate treatment for Paget's disease
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

New bisphosphonate treatment for Paget's disease
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Open-label Trial on the Effect of I.V. Zometa 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients with Bone Metastasis
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Pediatric Hypothalamic Obesity
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Safety & Efficacy of ICL670 vs. deferoxamine in Beta-thalassemia patients with iron overload due to blood transfusions
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Safety of ICL670 vs. deferoxamine in sickle cell disease patients with iron overload due to blood transfusions
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Study evaluating 4 oral doses of TCH346 and placebo administered once daily in patients with Amyotrophic Lateral Sclerosis (ALS)
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Study of ICL670 in iron overload from beta-thalassemia unable to be treated with deferoxamine or chronic anemias
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

The efficacy and safety of omalizumab in patients with severe persistent asthma
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

The Efficacy and Safety of Xolair in Children (6 - <12 years) with Moderate-Severe, Inadequately Controlled Allergic Asthma
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

To evaluate the ability of an investigational drug to reduce the rate of all subsequent skeletal fractures after a hip fracture.
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Treatment of patients with previously treated metastatic colorectal cancer with oxaliplatin/5FU/LV and PTK787 or placebo
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Treatment of VHL-related hemangioblastoma with PTK787/ZK 222584
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Treatment with Zometa in patients with breast cancer, multiple myeloma, and prostate cancer with cancer related bone lesions
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Zometa - Femara Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women with Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals



Novartis Pharmaceuticals Clinical Trials
Modify your Search

Other "N" Clinical Trials Sponsors:

Nabi Biopharmaceuticals
National Cancer Institute (nci)
National Cancer Institute Of Canada
National Cancer Research Institute (ncri)
National Center For Complementary And Alternative Medicine (nccam)
National Center For Research Resources (ncrr)
National Eye Institute (nei)
National Heart, Lung, And Blood Institute (nhlbi)
National Human Genome Research Institute (nhgri)
National Institute Of Allergy And Infectious Diseases (niaid)
National Institute Of Arthritis And Musculoskeletal And Skin Diseases (niams)
National Institute Of Child Health And Human Development (nichd)
National Institute Of Dental And Craniofacial Research (nidcr)
National Institute Of Diabetes And Digestive And Kidney Diseases (niddk)
National Institute Of Environmental Health Sciences (niehs)
National Institute Of Mental Health (nimh)
National Institute Of Neurological Disorders And Stroke (ninds)
National Institute Of Nursing Research (ninr)
National Institute On Aging (nia)
National Institute On Alcohol Abuse And Alcoholism (niaaa)
National Institute On Deafness And Other Communication Disorders (nidcd)
National Institute On Drug Abuse (nida)
National Library Of Medicine (nlm)
National Surgical Adjuvant Breast And Bowel Project (nsabp)
Neopharm
Neorx Corporation
Neotherapeutics
Neurex
Neurochem Inc.
Neurocrine Biosciences
Neurogesx
Neuropace
New Jersey Medical School
New York Gynecological Oncology Group
Newbiotics
Newport Pharmaceuticals International
Nexstar Pharmaceuticals
Nitromed
Nmrc Asia-Pacific Hepatocellular Carcinoma Trials Group
Nmrc Head And Neck Cancer Group
Nmrc International Colorectal Cancer Trials Group
Nmrc Nasopharyngeal Cancer Work Group
Nordic Society For Gynaecologic Oncology
Norris Cotton Cancer Center
North American Brain Tumor Consortium
North Central Cancer Treatment Group
Northfield Laboratories
Northwest Biotherapeutics
Northwestern Memorial Hospital
Northwestern University
Novacea
Novartis Pharmaceuticals
Novo Nordisk Pharmaceuticals
Novogen
Novum
Novuspharma
Nps Allelix Corp.
Nucryst Pharmaceuticals
Nuvelo


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103